Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery

NCT04161755 PHASE1 ACTIVE_NOT_RECRUITING

The purpose of this study is to evaluate the safety or treating pancreatic cancer with surgery to remove cancerour tissue, followed by atezolizumab, followed by a personalized cancer vaccine (PCV), and then with chemotherapy.

Details

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	PHASE1
Status	ACTIVE_NOT_RECRUITING
Enrolment	29
Start date	Fri Dec 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Nov 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Pancreatic Cancer

Interventions

• Atezolizumab
• RO7198457
• mFOLFIRINOX

Countries

United States